Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06431750 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT06431750 · ClinicalTrials.gov record · last posted 2026-08-07

Prospective Observational Study to Evaluate Secukinumab Treatment Effectiveness in Pediatric Patients With Active Juvenile Enthesitis-related or Psoriatic Arthritis

Name: Prospective Observational Study to Evaluate Secukinumab Treatment Effectiveness in Pediatric Patients With Active Juvenile Enthesitis-related or Psoriatic Arthritis — clinical trial record (NCT06431750)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: Toddler

StatusWithdrawn

PhaseNot specified

SponsorNovartis Pharmaceuticals

Started2025-04-30

View on ClinicalTrials.gov ↗

Why the trial stopped

Sponsor decision

from the ClinicalTrials.gov record

This is a multicenter, non-interventional, cohort study in pediatric patients with active juvenile enthesitis-related or psoriatic arthritis

Protocol amendment history 3 changes detected by DataLookout

2026-08-08

Withdrawn before enrolling

2026-08-08

Trial withdrawn: Sponsor decision

2026-08-08

Enrollment reduced: 150 → 0 participants

Trial Details

NCT Number	NCT06431750
Lead Sponsor	Novartis Pharmaceuticals
Conditions	Juvenile Idiopathic Arthritis
Start Date	2025-04-30
Primary Completion	2028-08-30 (estimated)
Study Completion	2028-08-30 (estimated)
Updated on ClinicalTrials.gov	2026-08-07